WO1997022694A3 - Diagnostic reagents relating to diabetes - Google Patents

Diagnostic reagents relating to diabetes Download PDF

Info

Publication number
WO1997022694A3
WO1997022694A3 PCT/CA1996/000867 CA9600867W WO9722694A3 WO 1997022694 A3 WO1997022694 A3 WO 1997022694A3 CA 9600867 W CA9600867 W CA 9600867W WO 9722694 A3 WO9722694 A3 WO 9722694A3
Authority
WO
WIPO (PCT)
Prior art keywords
sequence
nucleic acid
diabetes
diagnostic reagents
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CA1996/000867
Other languages
French (fr)
Other versions
WO1997022694A2 (en
Inventor
Catherine Jane Pallen
Lin Cui
Wei-Ping Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National University of Singapore
Original Assignee
National University of Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9526036.0A external-priority patent/GB9526036D0/en
Priority claimed from GBGB9605710.4A external-priority patent/GB9605710D0/en
Priority claimed from GBGB9620265.0A external-priority patent/GB9620265D0/en
Application filed by National University of Singapore filed Critical National University of Singapore
Priority to AU10909/97A priority Critical patent/AU1090997A/en
Priority to EP96941561A priority patent/EP0874901A2/en
Publication of WO1997022694A2 publication Critical patent/WO1997022694A2/en
Publication of WO1997022694A3 publication Critical patent/WO1997022694A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to a nucleic acid encoding a polypeptide that has the properties of an Insulin-dependent diabetes mellitus (IDDM)-associated autoantigen, which nucleic acid comprises: (a) the coding sequence of SEQ. ID. No. 1, 10 or 11, and/or the sequence complementary thereto; (b) a sequence which hybridises to a sequence defined in (a); (c) a sequence that is degenerate as a result of the genetic code to a nucleic acid sequence defined in (a) or (b); (d) a sequence having at least 80 % homology to a sequence defined in (a), (b) or (c). It also relates to the polypeptides encoded by such nucleic acids, and to diagnostic methods which employ such polypeptides.
PCT/CA1996/000867 1995-12-20 1996-12-20 Diagnostic reagents relating to diabetes Ceased WO1997022694A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU10909/97A AU1090997A (en) 1995-12-20 1996-12-20 Diagnostic reagents relating to diabetes
EP96941561A EP0874901A2 (en) 1995-12-20 1996-12-20 Diagnostic reagents relating to diabetes

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB9526036.0A GB9526036D0 (en) 1995-12-20 1995-12-20 Diagnostic reagents relating to diabetes
GB9526036.0 1995-12-20
GBGB9605710.4A GB9605710D0 (en) 1996-03-19 1996-03-19 Diagnostic reagents relating to diabetes
GB9605710.4 1996-03-19
GBGB9620265.0A GB9620265D0 (en) 1996-09-27 1996-09-27 Diagnostic reagents relating to diabetes
GB9620265.0 1996-09-27

Publications (2)

Publication Number Publication Date
WO1997022694A2 WO1997022694A2 (en) 1997-06-26
WO1997022694A3 true WO1997022694A3 (en) 1997-08-14

Family

ID=27268040

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA1996/000867 Ceased WO1997022694A2 (en) 1995-12-20 1996-12-20 Diagnostic reagents relating to diabetes

Country Status (3)

Country Link
EP (1) EP0874901A2 (en)
AU (1) AU1090997A (en)
WO (1) WO1997022694A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9160398A (en) * 1997-07-22 1999-02-16 Novimmune Sa Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
EP0893691A1 (en) * 1997-07-23 1999-01-27 Mach, Bernard François, Prof. Methods for diagnosis and therapy of autoimmunedisease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
US6355244B1 (en) 1997-11-17 2002-03-12 University Of Kentucky Research Foundation Methods and compositions for the treatment of psoriasis
US7785819B2 (en) * 2001-04-10 2010-08-31 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic and diagnostic uses of antibody specificity profiles
US7635559B2 (en) 2003-12-24 2009-12-22 Samsung Electronics Co., Ltd. Polynucleotide associated with a type II diabetes mellitus comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for analyzing polynucleotide using the same
KR100695147B1 (en) 2005-02-15 2007-03-14 삼성전자주식회사 Method for Diagnosing Type 2 Diabetes Using Multidentate Markers, Polynucleotides and Microarrays Containing Markers Associated with Type 2 Diabetes
DE202006010878U1 (en) 2006-07-11 2006-09-21 Takata-Petri Ag Airbag arrangement for vehicle occupant restraint system has chamber section that extends forward when airbag inflated to protect occupant including for forward occupant movements at angle by catching associated occupant body regions
US11806075B2 (en) * 2021-06-07 2023-11-07 Bolt Medical, Inc. Active alignment system and method for laser optical coupling

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991017186A1 (en) * 1990-05-04 1991-11-14 Rijksuniversiteit Te Leiden Beta cell antigen
WO1997007211A1 (en) * 1995-08-11 1997-02-27 THE GOVERNMENT OF THE UNITED STATES, represented by THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES Materials and methods for detection and treatment of insulin-dependent diabetes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991017186A1 (en) * 1990-05-04 1991-11-14 Rijksuniversiteit Te Leiden Beta cell antigen
WO1997007211A1 (en) * 1995-08-11 1997-02-27 THE GOVERNMENT OF THE UNITED STATES, represented by THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES Materials and methods for detection and treatment of insulin-dependent diabetes

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ADAMS M.D. ET AL.: "3400 new expressed sequence tags identify diversity of transcripts in human brain.", NATURE GENETICS, vol. 4, no. 3, July 1993 (1993-07-01), pages 256 - 267, XP000674622 *
CUI L. ET AL.: "Cloning and characterization of islet cell antigen-related protein-tyrosine phosphatase (PTP), a novel receptor-like PTP and autoantigen in insulin-dependent diabetes.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 271, no. 40, 4 October 1996 (1996-10-04), pages 24817 - 24823, XP002032721 *
KAWASAKI E. ET AL.: "Molecular cloning and characterization of the human transmembrane protein tyrosine phosphatase homologue, phogrin, an autoantigen of type 1 diabetes.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 227, no. 2, 14 October 1996 (1996-10-14), pages 440 - 447, XP002032722 *
LAN M S ET AL: "MOLECULAR CLONING AND IDENTIFICATION OF A RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE, IA-2, FROM HUMAN INSULINOMA", DNA AND CELL BIOLOGY, vol. 13, no. 5, May 1994 (1994-05-01), pages 505 - 514, XP000612611 *
PAYTON M.A. ET AL.: "Relationship of the 37.000 and 40.000 Mw tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512).", JOURNAL OF CLINICAL INVESTIGATION, vol. 96, September 1995 (1995-09-01), pages 1506 - 1511, XP000612574 *
SEISSLIER J. ET AL.: "Autoantibodies to tyrosine phosphatases IA-2 and IA-2 beta in insulin-dependent diabetes mellitus.", 32ND ANNUAL MEETING OF THE EUROPEAN ASSOCIATIONN FOR THE STUDY OF DIABETES, DIABETOLOGIA, vol. 39, no. SUPPL.1, 1 September 1996 (1996-09-01) - 5 September 1996 (1996-09-05), VIENNA, AUSTRIA, pages a85, XP000612637 *

Also Published As

Publication number Publication date
AU1090997A (en) 1997-07-14
EP0874901A2 (en) 1998-11-04
WO1997022694A2 (en) 1997-06-26

Similar Documents

Publication Publication Date Title
AU7550098A (en) System for expressing hyperthermostable protein
NZ505880A (en) IL-18 receptor polypeptides
CA2269111A1 (en) Genes encoding plant transcription factors
WO1997043409A3 (en) Method of providing novel dna sequences
AU3230797A (en) Dna encoding dp. 75 and a process for its use
CA2343715A1 (en) New human growth differentiation factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof
CA2294475A1 (en) Recombinant materials and methods for the production of limonene hydroxylases
WO1997022694A3 (en) Diagnostic reagents relating to diabetes
CA2204257A1 (en) Tripeptidyl aminopeptidase
AU697040B2 (en) Retrovirus from the HIV group and its use
NO177570B (en) Process for the preparation of peptides with fibronectin binding properties, microorganism and DNA sequence encoding peptides with fibronectin binding properties
ATE280232T1 (en) NUCLEOTIDE SEQUENCES CODING FOR THE DAPF GENE
EP0719862A3 (en) A regulatory factor for expression of nitrilase gene and a gene thereof
KR830003576A (en) How to isolate, purify and transfer human proinsulin precursors and proinsulin genes to microorganisms
AU4569293A (en) Anti-feline immunodeficiency virus (fiv) vaccines
CA2045839A1 (en) Cloned n-methylhydantoinase
EP0773290A3 (en) Novel LDL receptor analog protein and the gene coding therefor
CA2301902A1 (en) Novel extracellular serine protease
WO1999045107A8 (en) Novel calpain and dna encoding the same
TW342413B (en) Novel toxins isolated from Bracon Hebetor
EP1111058A4 (en) A novel human lysozyme gene, its encoding polypeptide and the method for preparing them
WO2000017232A3 (en) Regulatory protein from human keratinocytes
MX9804053A (en) Malathion carboxylesterase.
EP0828004A3 (en) Protein disulfide isomerase gene derived from strain of methylotrophic yeast
WO2001053456A3 (en) Methods and materials relating to prothrombinase-like polypeptides and polynucleotides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1996941561

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97522384

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1996941561

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1996941561

Country of ref document: EP